Corrigendum to “Effect of perioperative COX-2 and beta-adrenergic inhibition on 5-year disease-free-survival in colorectal cancer: A pilot randomized controlled Colorectal Metastasis PreventIon Trial (COMPIT)” [Eur J Surg Oncol 49 (3) (2023) 655–661, (S0748798322007053), (10.1016/j.ejso.2022.10.013)]

Itay Ricon-Becker, Rita Haldar, Maytal Shabat Simon, Mordechai Gutman, Steve W. Cole, Shagmar Ben-Eliyahu, Oded Zmora

Research output: Contribution to journalComment/debate

Abstract

The authors regret a mistake in listing the funding agencies. A grant from the Israel Cancer Research Foundation (ICRF) to SBE funded this study. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number107979
JournalEuropean Journal of Surgical Oncology
Volume50
Issue number3
DOIs
StatePublished - Mar 2024

All Science Journal Classification (ASJC) codes

  • Oncology
  • Surgery

Fingerprint

Dive into the research topics of 'Corrigendum to “Effect of perioperative COX-2 and beta-adrenergic inhibition on 5-year disease-free-survival in colorectal cancer: A pilot randomized controlled Colorectal Metastasis PreventIon Trial (COMPIT)” [Eur J Surg Oncol 49 (3) (2023) 655–661, (S0748798322007053), (10.1016/j.ejso.2022.10.013)]'. Together they form a unique fingerprint.

Cite this